Scholarlink

<p>Adherence to surveillance recommendations for Barrett’s esophagus (BE) has been little studied. This study evaluated adherence to current guidelines in Spain, factors associated with deviations from recommendations, and the impact on progression. It was a prospective, observational, multicenter study of patients with BE between January 2016 and December 2022. 375 patients (80.5% males, age 55 ± 13&#xa0;years) were followed for 50 (IQR 34–61) months and underwent 556 gastroscopies, 505(90.8%) for surveillance. Among these, only 206(40.8%) were performed within the recommended intervals and 254(50.3%) were early endoscopies. Risk factors for early endoscopy were short BE length (&lt; 3&#xa0;cm 59.5% vs. ≥ 3&#xa0;cm 42.2%, OR 2.01(1.35–2.98)) and endoscopy referred by a surgeon (7.2% vs. 2.8%, OR 2.99(1.19–7.52)), whereas use of the Seattle protocol (68% vs 79.9%, OR 0.51(0.32–0.8)) was protective. BE progression was confirmed in 13 patients (3.4%): 7 low-grade dysplasia, 5 high-grade dysplasia or in-situ adenocarcinoma, and 1 invasive adenocarcinoma. The median time from BE diagnosis to progression was 48&#xa0;months (IQR 28–59). Early endoscopy did not significantly increased detection of BE progression (3.1% vs 2%, p = 0.41). The only independent risk factor for progression was BE length (OR 9.39 (2.02–43.78)). In conclusion, adherence to BE surveillance guidelines in Spain is low and the tendency to early endoscopy is notable. Improving adherence could reduce unnecessary procedures without compromising patient outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Adherence to Barrett’s esophagus surveillance guidelines and its impact on progression: a multicenter prospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月25日

查看全文
  • Marianette Murzi-Pulgar,
  • Alain Huerta,
  • Cristina Sánchez-Montes,
  • Luis Hernández,
  • Manuel Dominguez Cajal,
  • David Nicolas-Perez,
  • Marina Puya Gamarro,
  • Marta Aicart-Ramos,
  • Alba Lira,
  • Norberto Mañas Gallardo,
  • Jorge López Vicente,
  • Pablo Ruiz-Ramírez,
  • Elida Oblitas,
  • Carlos Huertas,
  • Eloi Nuñez Garcia,
  • Guillem Iborra,
  • Jorge Luis Núñez-Pizarro,
  • Lidia Argüello-Viudez,
  • Ángeles Cristina Pérez Aisa,
  • Enrique De la Fuente Fernández,
  • Carme Loras,
  • Hugo Uchima,
  • Antonio Giordano,
  • Carlos Guarner-Argente,
  • Glòria Fernández-Esparrach

摘要

Adherence to surveillance recommendations for Barrett’s esophagus (BE) has been little studied. This study evaluated adherence to current guidelines in Spain, factors associated with deviations from recommendations, and the impact on progression. It was a prospective, observational, multicenter study of patients with BE between January 2016 and December 2022. 375 patients (80.5% males, age 55 ± 13 years) were followed for 50 (IQR 34–61) months and underwent 556 gastroscopies, 505(90.8%) for surveillance. Among these, only 206(40.8%) were performed within the recommended intervals and 254(50.3%) were early endoscopies. Risk factors for early endoscopy were short BE length (< 3 cm 59.5% vs. ≥ 3 cm 42.2%, OR 2.01(1.35–2.98)) and endoscopy referred by a surgeon (7.2% vs. 2.8%, OR 2.99(1.19–7.52)), whereas use of the Seattle protocol (68% vs 79.9%, OR 0.51(0.32–0.8)) was protective. BE progression was confirmed in 13 patients (3.4%): 7 low-grade dysplasia, 5 high-grade dysplasia or in-situ adenocarcinoma, and 1 invasive adenocarcinoma. The median time from BE diagnosis to progression was 48 months (IQR 28–59). Early endoscopy did not significantly increased detection of BE progression (3.1% vs 2%, p = 0.41). The only independent risk factor for progression was BE length (OR 9.39 (2.02–43.78)). In conclusion, adherence to BE surveillance guidelines in Spain is low and the tendency to early endoscopy is notable. Improving adherence could reduce unnecessary procedures without compromising patient outcomes.